Rare childhood diseases: how should we respond?

Area of Science:

• Public Health
• Genetics
• Pediatrics

Background:

• Rare diseases collectively affect 6-10% of the population, posing significant burdens.
• Impacts extend to patients, families, healthcare systems, and communities.
• Accurate data is crucial for informed clinical practice, policy, and health service planning.

Purpose of the Study:

• To highlight the prevalence and impact of rare diseases.
• To advocate for a national approach to rare disease management.
• To promote research, advocacy, and equitable access to services for children with rare diseases.

Main Methods:

• Literature review and synthesis of existing data on rare diseases.
• Analysis of the impact on various stakeholders.
• Comparative analysis of international rare disease strategies (USA, Europe).

Main Results:

• Rare diseases are a substantial public health concern due to their collective prevalence.
• Current data collection and service provision may be fragmented.
• International models demonstrate the potential of national strategies.

Conclusions:

• A unified national approach is recommended for rare diseases in children.
• Such a strategy should foster research, patient advocacy, and equitable service access.
• Implementing a national framework can improve outcomes for children with rare diseases.